Archive: big pharma

Premium
In a slightly less broken world, Enosi Life Sciences would not exist as is. Enosi is a tiny drug research and development company. And that is the only ordinary-sounding thing about it. Its technology is not ordinary. Its rockstar founders are far from ordinary. And its vision to create a new, more powerful and safer generation of autoimmune, anti-inflammation and cancer-fighting drugs is extraordinarily ambitious — and well within reach.  Enosi is a product…
Premium
Deal Details Startup: Responsum Health Security type: Crowd SAFE* Valuation (cap): $4.5 million Discount: 0% Minimum investment: $100 Where to invest: Republic Deadline: January 2, 2022…

T. Boone Pickens’ Real Legacy Has Nothing to Do With Oil

By Vin Narayanan on September 14, 2019

This week, the News Fix is dedicated to legendary disruptor T. Boone Pickens. His true legacy went far beyond oil.

Equity Crowdfunding Is Hitting Its Stride

By Adam Sharp on February 1, 2019

Software is changing the way every business operates. It spells trouble for large, debt-laden companies that are slow to modernize their tech, but it’s a huge opportunity for startups.